AU2014256372B2 - New compositions for treating CMT and related disorders - Google Patents

New compositions for treating CMT and related disorders

Info

Publication number
AU2014256372B2
AU2014256372B2 AU2014256372A AU2014256372A AU2014256372B2 AU 2014256372 B2 AU2014256372 B2 AU 2014256372B2 AU 2014256372 A AU2014256372 A AU 2014256372A AU 2014256372 A AU2014256372 A AU 2014256372A AU 2014256372 B2 AU2014256372 B2 AU 2014256372B2
Authority
AU
Australia
Prior art keywords
related disorders
new compositions
treating cmt
cmt
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2014256372A
Other versions
AU2014256372A1 (en
Inventor
Ilya Chumakov
Daniel Cohen
Serguei Nabirochkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharnext SA
Original Assignee
Pharnext SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010255802A external-priority patent/AU2010255802B2/en
Application filed by Pharnext SA filed Critical Pharnext SA
Priority to AU2014256372A priority Critical patent/AU2014256372B2/en
Publication of AU2014256372A1 publication Critical patent/AU2014256372A1/en
Application granted granted Critical
Publication of AU2014256372B2 publication Critical patent/AU2014256372B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

HAaintewo..venNRPonbl\DCC\AARM93039_ L.dccx-30/10/2014 - 55a The present invention relates to compositions and methods for the treatment of the Charcot Marie-Tooth disease and related disorders.
AU2014256372A 2009-06-02 2014-10-30 New compositions for treating CMT and related disorders Ceased AU2014256372B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014256372A AU2014256372B2 (en) 2009-06-02 2014-10-30 New compositions for treating CMT and related disorders

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09305506.9 2009-06-02
AU2010255802A AU2010255802B2 (en) 2009-06-02 2010-05-28 New compositions for treating CMT and related disorders
AU2014256372A AU2014256372B2 (en) 2009-06-02 2014-10-30 New compositions for treating CMT and related disorders

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2010255802A Division AU2010255802B2 (en) 2009-06-02 2010-05-28 New compositions for treating CMT and related disorders

Publications (2)

Publication Number Publication Date
AU2014256372A1 AU2014256372A1 (en) 2014-11-20
AU2014256372B2 true AU2014256372B2 (en) 2016-07-14

Family

ID=51900641

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014256372A Ceased AU2014256372B2 (en) 2009-06-02 2014-10-30 New compositions for treating CMT and related disorders

Country Status (1)

Country Link
AU (1) AU2014256372B2 (en)

Also Published As

Publication number Publication date
AU2014256372A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
MX2011012817A (en) New compositions for treating cmt and related disorders.
MX2018009945A (en) Novel compositions and methods for the treatment of immune related diseases.
IN2012DN03883A (en)
AU2016219704A1 (en) Anti-Notch1 antibodies
MY163275A (en) Ibat inhibitors for the treatment of liver diseases
MX2011007930A (en) Crystalline insulin-conjugates.
TR201819564T4 (en) Novel therapeutic approaches for the treatment of Cmt and related disorders.
MX2022009942A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same.
UA108198C2 (en) Substituted 2-acetamido-5-aryl-l, 2,4-triazolones and their use
MY171866A (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
IN2012DN02081A (en)
MX2010002732A (en) F1f0-atpase inhibitors and related methods.
IN2012DN00624A (en)
MX2011008602A (en) Methods of treating hair related conditions.
MX2012010434A (en) Novel compounds and compositions for targeting cancer stem cells.
MX2009013353A (en) Telomerase activating compounds and methods of use thereof.
MX2009005725A (en) Methods and compositions for treating and monitoring treatment of il-13-associated disorders.
MX2011013032A (en) Inhibitors of phosphatidylinositol 3-kinase.
MX2012001134A (en) Compositions and methods for inhibition of the jak pathway.
AU2010306870A8 (en) Reducing the risk of pathological effects of traumatic brain injury
MX2013002121A (en) Substituted quinoline-3-carboxamides as kcnq2/3 modulators.
MX342119B (en) Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators.
MX357166B (en) Antibodies to notum pectinacetylesterase.
MX2011008645A (en) Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase.
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired